Literature DB >> 11138787

The role of chemokines in human immunodeficiency virus infection.

A Garzino-Demo1, A L DeVico, K E Conant, R C Gallo.   

Abstract

Chemokines that bind to human immunodeficiency virus (HIV) co-receptors are potent and selective inhibitors of HIV infection. Therefore, ever since our discovery of this activity, we have proposed their role in controlling HIV infection as a third arm of the immune response, i.e. in concert with humoral and cellular responses. Research carried out in our laboratory, and performed independently by other groups, has recently strengthened this concept. Here, we critically analyze the evidence indicating the positive contribution of chemokines to HIV infection, their involvement with cognate and innate immunity, and the potential for their use in combating HIV infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11138787     DOI: 10.1034/j.1600-065x.2000.17711.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  11 in total

1.  Blocking HIV-1 infection via CCR5 and CXCR4 receptors by acting in trans on the CCR2 chemokine receptor.

Authors:  José Miguel Rodríguez-Frade; Gustavo del Real; Antonio Serrano; Patricia Hernanz-Falcón; Silvia F Soriano; Antonio J Vila-Coro; Ana Martín de Ana; Pilar Lucas; Ignacio Prieto; Carlos Martínez-A; Mario Mellado
Journal:  EMBO J       Date:  2003-12-11       Impact factor: 11.598

Review 2.  Endocytic trafficking of chemokine receptors.

Authors:  Adriano Marchese
Journal:  Curr Opin Cell Biol       Date:  2013-12-14       Impact factor: 8.382

3.  Simian immunodeficiency virus infection alters chemokine networks in lung tissues of cynomolgus macaques: association with Pneumocystis carinii infection.

Authors:  Shulin Qin; Beth A Fallert Junecko; Anita M Trichel; Patrick M Tarwater; Michael A Murphey-Corb; Denise E Kirschner; Todd A Reinhart
Journal:  Am J Pathol       Date:  2010-07-29       Impact factor: 4.307

4.  Administration of recombinant rhesus interleukin-12 during acute simian immunodeficiency virus (SIV) infection leads to decreased viral loads associated with prolonged survival in SIVmac251-infected rhesus macaques.

Authors:  A A Ansari; A E Mayne; J B Sundstrom; P Bostik; B Grimm; J D Altman; F Villinger
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

5.  Baboon CD8 T cells suppress SIVmac infection in CD4 T cells through contact-dependent production of MIP-1α, MIP-1β, and RANTES.

Authors:  Veronica Obregon-Perko; Vida L Hodara; Laura M Parodi; Luis D Giavedoni
Journal:  Cytokine       Date:  2018-05-26       Impact factor: 3.861

6.  Chemokine receptor CCR5 mediates alloimmune responses in graft-versus-host disease.

Authors:  Lisa A Palmer; George E Sale; John I Balogun; Dan Li; Dan Jones; Jeffrey J Molldrem; Rainer F Storb; Qing Ma
Journal:  Biol Blood Marrow Transplant       Date:  2009-12-16       Impact factor: 5.742

7.  HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses.

Authors:  Sayed F Abdelwahab; Fiorenza Cocchi; Kenneth C Bagley; Roberta Kamin-Lewis; Robert C Gallo; Anthony DeVico; George K Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

8.  Glial TNFα in the spinal cord regulates neuropathic pain induced by HIV gp120 application in rats.

Authors:  Wenwen Zheng; Handong Ouyang; Xuexing Zheng; Shue Liu; Marina Mata; David J Fink; Shuanglin Hao
Journal:  Mol Pain       Date:  2011-05-20       Impact factor: 3.395

9.  Macrophage Resistance to HIV-1 Infection Is Enhanced by the Neuropeptides VIP and PACAP.

Authors:  Jairo R Temerozo; Rafael Joaquim; Eduardo G Regis; Wilson Savino; Dumith Chequer Bou-Habib
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

10.  Can non-lytic CD8+ T cells drive HIV-1 escape?

Authors:  Nafisa-Katrin Seich Al Basatena; Konstantinos Chatzimichalis; Frederik Graw; Simon D W Frost; Roland R Regoes; Becca Asquith
Journal:  PLoS Pathog       Date:  2013-11-14       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.